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Abstract We determined insulin-stimulated Na+,K+-ATPase
isoform-speci¢c translocation to the skeletal muscle plasma
membrane. When rat muscle plasma membrane fractions were
isolated by discontinuous sucrose gradients, insulin-stimulated
translocation of K2- but not K1-subunits was detected. However,
using cell surface biotinylation techniques, an insulin-induced
membrane translocation of both K1 and K2-subunits in rat epi-
trochlearis muscle and cultured human skeletal muscle cells was
noted. Na+,K+-ATPase K-subunit translocation was abolished
by the phosphatidylinositol (PI) 3-kinase inhibitor wortmannin,
as well as by the protein kinase C inhibitor GF109203X. Thus,
insulin mediates Na+,K+-ATPase K1- and K2-subunit transloca-
tion to the skeletal muscle plasma membrane via a PI 3-kinase-
dependent mechanism.
0 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Naþ,Kþ-ATPase is a plasma membrane (PM) pump essen-
tial for maintenance of intracellular and extracellular sodium
and potassium concentrations, cell volume and electrochemi-
cal gradients [1,2]. Skeletal muscle contains one of the largest
pools of Naþ,Kþ-ATPase [3] and expresses K- (K1 and K2)
and L- (L1 and L2) subunits [4,5]. Insulin regulates Kþ uptake
through stimulation of Naþ,Kþ-ATPase, which is not second-
ary to an increase in [Naþ]i via Naþ^Hþ antiporter stimula-
tion [6]. Insulin-stimulated Na-pump activity occurs via a pro-
tein kinase C (PKC)-dependent pathway [7,8], and increases
the number of active Naþ,Kþ-ATPase molecules at the cell
surface [5,9]. In rat skeletal muscle membrane fractions iso-
lated by di¡erential centrifugation and discontinuous sucrose
gradients, insulin promotes K2- and L1-subunit translocation
to the PM, with no change in K1- and L2-distribution [8,9]. A
common explanation for this observation is that the ubiqui-
tously expressed Naþ,Kþ-ATPase K1-subunit isoform has a
‘housekeeping’ function, whereas the K2-subunit isoform is
hormone-sensitive and primarily responsible for e¡ects of in-
sulin on Naþ,Kþ-ATPase activity. In skeletal muscle,
Naþ,Kþ-ATPase K-subunits are phosphorylated on serine/
threonine and tyrosine residues in response to insulin [8].
However, the signaling pathways, and nature of the protein
kinases involved in insulin-mediated Naþ,Kþ-ATPase regula-
tion are unknown.
We determined insulin-stimulated Naþ,Kþ-ATPase K-sub-
unit membrane tra⁄cking in rat skeletal muscle by utilizing
di¡erent cell surface protein isolation techniques. Furthermore
we compared species-speci¢c responses for Na-pump tra⁄ck-
ing using rat skeletal muscle and di¡erentiated primary hu-
man skeletal muscle cells (HSMC). Using cell-surface biotin-
ylation technique and protein kinase inhibitors, we identify a
signal transduction pathway involved in insulin-stimulated
Naþ,Kþ-ATPase K-subunit translocation in skeletal muscle.
2. Materials and methods
2.1. Materials
Cell culture supplies were obtained from Gibco BRL (Life-Tech-
nologies, Sweden). Human insulin (Actrapid) was from Novo Nordisk
(Copenhagen, Denmark). Wortmannin and GF109203X were from
Calbiochem (La Jolla, CA, USA). Streptavidin-agarose beads and
EZ-link Sulfo-NHS-SS-biotin were from Pierce, (Rockford, IL,
USA). All other reagents were analytical grade (Sigma, St. Louis,
MO, USA). Speci¢c anti-K1-subunit monoclonal [10] and anti-K2-sub-
unit monoclonal [11] antibodies were obtained from Drs. M. Caplan
(Yale University, CT, USA) and K. Sweadner (Massachusetts Central
Hospital, MA, USA). Stockholm’s North Ethical Committee ap-
proved the animal experiments. The Ethical Committee of Huddinge
University Hospital approved the human experiments.
2.2. Subcellular fractionation of rat skeletal muscle membranes
Overnight-fasted male Wistar rats (120^130 g) were anesthetized by
an intraperitoneal (i.p.) injection of sodium pentobarbital (5 mg/100 g
body weight). Animals were injected with either insulin (0.75 U of
insulin/100 g body weight, i.p.) or an equal volume of saline (control
group) 30 min prior to being sacri¢ced. Hindlimb muscles were re-
moved and frozen in liquid nitrogen. Cell surface and intracellular
membrane (IM) fractions were isolated from V350 mg of gastrocne-
mius muscle by di¡erential centrifugation and discontinuous sucrose
gradients [8,9]. After centrifugation of the discontinuous sucrose gra-
dients three protein fractions were collected: fraction 25 (on top of the
25% layer), fraction 30 (from the interphase 25^30%), and fraction 35
(from the interphase 30^35%). Protein concentration was determined
using the BCA assay (Pierce, Rockford, IL, USA). Fraction 25 cor-
responds to a cell surface membrane fraction enriched with PM,
whereas fraction 35 corresponds to IMs [9,12,13]. Protein recovery
yield (calculated as percent of protein content in crude membranes
in ¢ve membrane preparations) was 3.4 O 0.3% for PM and 9.8O 0.8%
for IM fraction, respectively. Protein recovery was not a¡ected by
insulin.
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2.3. Epitrochlearis muscle incubation
Overnight-fasted rats were anesthetized with sodium pentobarbital
(5 mg/100 g body weight, i.p.). Epitrochlearis muscles were incu-
bated without or with 120 nM insulin in the absence or presence of
kinase inhibitors [10]. Muscles were washed three times with ice-
cold phosphate-bu¡ered saline (PBS), placed in 12-well cell culture
plates on ice and incubated with biotinylated reagent described
below.
2.4. Cell culture, di¡erentiation and incubation
Skeletal muscle biopsies were obtained with the informed consent of
healthy donors during scheduled abdominal surgery. Satellite cells
were isolated and cultures were established as described for human
fetal skeletal muscle [14]. At con£uence (s 80%) cells were trypsinized
and subcultured. To initiate di¡erentiation, Hams-F10/20% FBS me-
dium was replaced with DMEM containing 4% FBS for 48 h, and
thereafter, with DMEM containing 2% FBS. Fusion and multinuclea-
tion of the cells was observed 3 days after initiation of di¡erentiation
protocol. Myotubes were used 7 days after di¡erentiation. Studies
were performed on the second or third passage.
Cells were serum starved overnight and then incubated in the ab-
sence or presence of 120 nM insulin (20 min at 37‡C). When pharma-
cological inhibitors were used, 20 min incubation was introduced to
pre-expose cells to the inhibitor. Inhibitors remained present for the
duration of the experiment. After incubation, cells were washed three
times with ice-cold PBS and incubated with biotinylated reagent de-
scribed below.
2.5. Cell surface biotinylation
Epitrochlearis muscles or di¡erentiated HSMC were exposed to EZ-
link Sulfo-NHS-SS-biotin at ¢nal concentration 1.5 mg/ml in PBS at
4‡C for 60 min with gentle shaking. Thereafter, medium was aspirated
and un-reacted Sulfo-NHS-SS-biotin was quenched with PBS contain-
ing 100 mM of glycine. Isolated skeletal muscle or cultured cells were
washed three times with ice-cold PBS, and excess PBS was aspirated.
Before solubilization, epitrochlearis muscles were frozen and pulver-
ized in liquid nitrogen. Samples were solubilized in 1 ml of ice-cold
lysis bu¡er containing 20 mM Tris, pH 8.0, 135 mM NaCl, 1 mM
MgCl2, 2.7 mM KCl, 10 mM Na4P2O7, 10 mM NaF, 1 mM Na3VO4,
1 WM okadaic acid, 1% Triton X-100, 10% v/v glycerol, 0.2 mM
phenylmethylsulfonyl £uoride and 10 Wg/ml each of aprotinin, leupep-
tin and pepstatin. Cell lysates were then transferred to microcentrifuge
tubes and rotated for 60 min at 4‡C. Insoluble material was removed
by centrifugation (12 000Ug for 10 min at 4‡C). Protein was deter-
mined using a BCA assay (Pierce, Rockford, IL, USA). Supernatants
(1 mg of protein for muscle lysate and 250 Wg of protein for cell lysate,
respectively) were collected and mixed with 50 Wl streptavidin-agarose
beads (50% suspension in PBS, Pierce, Rockford, IL, USA) to form a
streptavidin^biotin complex. Samples were incubated overnight at
4‡C. Beads were washed four times with PBS containing 0.1% Triton
X-100, and twice with PBS. Laemmeli bu¡er (60 Wl) was added to
each sample, and heated for 56‡C for 20 min. Samples were subjected
to SDS^PAGE.
2.6. Western blot analysis
Aliquots of plasma or IMs (10 Wg of protein) or bead pellets after
precipitation of biotinylated proteins were mixed with Laemmli-sam-
ple bu¡er, and proteins were separated on 7.5% SDS^PAGE. Proteins
were transferred to polyvinylidenedi£uoride membranes (Millipore,
Bedford, MA, USA) and subjected to Western blot analysis as de-
scribed [8]. After incubation with primary antibody, membranes were
washed and incubated with secondary antibody linked to horseradish
peroxidase (Bio-Rad Laboratories, Hercules, CA, USA). Naþ,Kþ-
ATPase K-subunit isoforms were visualized with enhanced chemilumi-
nescence (Amersham Biosciences, Little Chalfont, UK). Multiple ¢lm
exposures were used to ensure that Naþ,Kþ-ATPase K-subunits de-
tected in linear range of protein bands saturation. Results were quan-
ti¢ed by densitometry using Gel Doc 1000 imaging system with Mo-
lecular Analyst software, version 1.5 (Bio-Rad Laboratories, Hercules,
CA, USA).
2.7. Statistics
Comparisons between groups were performed using Student’s t-test.
For multiple comparisons, one-way ANOVA with She¡e’s correction
was used. Signi¢cance was established at P6 0.05.
3. Results
3.1. Subcellular fractionation
In rat hindlimb skeletal muscle membranes, insulin in-
creased Naþ,Kþ-ATPase K2-subunit abundance in the PM
fraction 41% (P6 0.01, n=5), with a parallel 36% decrease
(P6 0.05, n=6) in K2-subunit abundance in the IM fraction
(Fig. 1C,D). K1-Subunit expression in the PM fraction was
not altered, whereas, insulin reduced (22%; P6 0.05, n=8),
K1-subunit content in the IM fraction (Fig. 1B).
3.2. Cell surface biotinylation
Insulin markedly increased cell surface Naþ,Kþ-ATPase
content in isolated rat epitrochlearis muscle (Fig. 2A,B). In
contrast to results obtained using subcellular fractionation
methods, insulin induced translocation of K1- and K2-subunits
to the cell surface (as a percentage of basal: 51% increase for
Fig. 1. Subcellular fractionation of rat skeletal muscle membranes.
Rats were injected with saline (Basal) or insulin (Ins). Membranes
from mixed skeletal muscle were isolated by di¡erential centrifuga-
tion and discontinuous sucrose gradient. Protein from cell surface
PMs and IMs fractions were resolved by SDS^PAGE and distribu-
tion of K1- (A,B) and K2-subunits (C,D) of Naþ,Kþ-ATPase was
determined by Western blot using speci¢c monoclonal antibodies.
Representative immunoblots (upper panel) and quantitative data
from 5^8 experiments (meanOS.E.M.) (lower panel) are shown.
*P6 0.05 vs. basal.
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K1 and 74% increase for K2, respectively, P6 0.05, n=6).
Translocation of K1- and K2-subunits of Naþ,Kþ-ATPase to
the cell surface was abolished by the phosphatidylinositol (PI)
3-kinase inhibitor wortmannin, as well as the PKC inhibitor
GF109203X (Fig. 2A,B).
The primary structure, phosphorylation sites and ouabain
sensitivity of Naþ,Kþ-ATPase K-subunits di¡er between rat
and human [1,2,15]. Thus, we examined Naþ,Kþ-ATPase
K-subunit PM content in primary HSMC di¡erentiated to
myotubules. Incubation of di¡erentiated HSMC with 120
nM insulin for 20 min increased PM content of the K1
and K2-subunit (as a percentage of basal: 73% increase for
K1 and 97% increase for K2, respectively, P6 0.01, n=6, Fig.
2C,D). Insulin-induced Naþ,Kþ-ATPase K-subunit transloca-
tion to HSMC PM was abolished by PI 3-kinase and PKC
inhibitors (Fig. 2C,D). Notably, 1 WM of GF109203X, a con-
centration that inhibits conventional and novel, but not
atypical PKCs [16], did not inhibit insulin action (data not
shown).
4. Discussion
Subcellular fractionation experiments provided evidence
that the Naþ,Kþ-ATPase K2-subunit, together with glucose
transporter GLUT4, are insulin-responsive proteins in skeletal
muscle, while K1-subunit translocation has been thought to be
regulated in an insulin-independent manner [2,9,17]. However,
using alternative techniques for monitoring protein tra⁄cking,
the K1-subunit has been shown to undergo hormone-sensitive
translocation to the PM, at least in cells of kidney origin.
Insulin promotes translocation of an exofacially epitope-
tagged rat Naþ,Kþ-ATPase K1-subunit to the PM in HEK-
293 cells [18]. Cell surface biotinylation has also been used to
show translocation of K1-isoform in rat cortical collecting
duct cells in response to an increase in cAMP [19]. Consistent
with these ¢ndings, using a novel and sensitive biotinylation
technique we demonstrate that insulin induces not only
Naþ,Kþ-ATPase K2-, but also K1-subunit translocation to
the cell surface in skeletal muscle.
Fig. 2. Translocation of Naþ,Kþ-ATPase K-subunit to the cell surface in absence or presence of insulin and PI 3-kinase or PKC inhibitors.
Rat epitrochlearis muscle (A,B) and human di¡erentiated myotubules (C,D) were incubated without or with 120 nM insulin and in the absence
or presence of either 100 nM wortmannin, or 10 WM GF109203X. Cell surface Naþ,Kþ-ATPase abundance was determined by biotinylation
with EZ-link Sulfo-NHS-SS-biotin and streptavidin-precipitation as described in Section 2. Naþ,Kþ-ATPase K1- (A,C) and K2-subunits (B,D)
were determined as described in Fig. 1. Representative blots (upper panel) and quantitative data from six experiments (meanOS.E.M.) (lower
panel) are shown. *P6 0.01 vs. basal.
FEBS 26962 5-2-03
L. Al-Khalili et al./FEBS Letters 536 (2003) 198^202200
The structural complexity of skeletal muscle tissue, with
inherent di⁄culties in applications of gene transfection and
optical techniques has made subcellular fractionation and gra-
dient centrifugation the preferred and almost irreplaceable
tool for isolation of membrane compartments to study
membrane proteins tra⁄cking [8,9,12,20]. However, skeletal
muscle surface membranes include both sarcolemma and
T-tubules, and the large content of myo¢brils and connective
tissue prevents proper separation of membrane fractions. An-
other di⁄culty associated with subcellular fractionation is the
low yield (0.7^8%) of PM/sarcolemma recovery [21]. Thus,
even without a noticeable increase in K1-subunit abundance
in the PM fraction, a reduction of K1-subunit abundance in
the IM fraction can be taken as evidence for an insulin-sensi-
tive K1-subunit pool. Importantly, a previous comparative
study [22] provides evidence that the method utilized in this
study, as well as in previously reports [8,9,12,13], concerning
isoform-speci¢c translocation of Naþ,Kþ-ATPase K2-subunits
in response to insulin, has a better recovery of intracellular
compartments as compared to the PM technique. Thus, the
subfraction containing the target PM for the insulin-sensitive
pool of K1-subunit may not be recovered on sucrose gradient,
whereas an increase in K1-isoform abundance in response to
insulin is signi¢cant and measurable by labeling of cell surface
Naþ,Kþ-ATPase, although the magnitude of the response is
greater in case of K2-subunit. Surface labeling of Naþ,Kþ-
ATPase molecules in isolated skeletal muscles ex vivo may
be an important approach for studying Naþ,Kþ-ATPase traf-
¢c, as it permits the use of inhibitors of di¡erent signaling
molecules. The same methodology could be used for visual-
ization of possible Naþ,Kþ-ATPase tra⁄cking defects in
muscles from experimental animal models. However, despite
the caveats mentioned above, subcellular fractionation and
gradient centrifugation will remain an important method to
study membrane tra⁄cking in skeletal muscle when su⁄cient
quantities of tissue are available; especially as the mild con-
ditions of the method makes it possible to assess enzymatic
activity and study protein interactions in membrane fractions.
Rat skeletal muscle and di¡erentiated myotubules of human
origin exhibit a similar response of Naþ,Kþ-ATPase subunits
to insulin and inhibitors of PI 3-kinase and PKC, despite
species-speci¢c di¡erences in the primary structure of
Naþ,Kþ-ATPase K-subunits, sensitivity to ouabain, and spe-
ci¢c location of phosphorylation sites recognized by di¡erent
protein kinases. For example, human K1-subunit lacks Ser-18,
an amino acid residue critically involved in rat K1-subunit
endocytosis [23]. Despite these species-speci¢c di¡erences,
our data suggests there are also novel common mechanisms
of insulin-regulated Naþ,Kþ-ATPase activity. Since cultured
HSMC express multiple isoforms of Naþ,Kþ-ATPase, they
provide a good model for studying di¡erential regulation of
multiple human Naþ,Kþ-ATPase isoforms, whose functional
di¡erences in speci¢c cell types remain poorly understood.
Activation of PI 3-kinase and further activation of atypical
PKC h and V by PI 3-kinase lipid products is essential for
insulin-stimulated GLUT4 translocation [24]. However,
whether the same mechanism(s) are involved in the transloca-
tion of Naþ,Kþ-ATPase is not clear. Morphological data in-
dicates GLUT4 and Naþ,Kþ-ATPase do not co-localize in the
same intracellular compartments in skeletal muscle [17].
Nevertheless, pre-incubation with wortmannin or atypical
PKC inhibitors abolished insulin-induced activation of Naþ,
Kþ-ATPase in ¢broblasts and epithelial cells [25,26]. Here we
demonstrate that K1- and K2-subunits of Naþ,Kþ-ATPase
translocate to the PM in rat and human skeletal muscle via
pathways dependent on PI 3-kinase and atypical PKCs, a
¢nding consistent with recent report showing wortmannin
and the PKC inhibitor, bisindoleilmalemid, prevents insulin-
stimulated translocation of rat K1-subunit overexpressed in
HEK-293 cells [18]. Since atypical, but not conventional and
novel PKC isoforms are involved in insulin-stimulated phos-
phorylation of Naþ,Kþ-ATPase K-subunits in intact rat skel-
etal muscle [8], phosphorylation of the K-subunits may be a
triggering signal for translocation to PM.
In summary, insulin induces translocation of K1- and K2-
subunits of Naþ,Kþ-ATPase to the PM in intact skeletal
muscle or muscle cells in culture. Our observation highlights
the need for veri¢cation of results regarding tra⁄cking of
membrane proteins obtained by subcellular fractionation tech-
niques by techniques of direct labeling of cell surface or intra-
cellular proteins.
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